AU2002237195A1 - Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus - Google Patents
Recombinant poxvirus for chimeric proteins of the human immunodeficiency virusInfo
- Publication number
- AU2002237195A1 AU2002237195A1 AU2002237195A AU2002237195A AU2002237195A1 AU 2002237195 A1 AU2002237195 A1 AU 2002237195A1 AU 2002237195 A AU2002237195 A AU 2002237195A AU 2002237195 A AU2002237195 A AU 2002237195A AU 2002237195 A1 AU2002237195 A1 AU 2002237195A1
- Authority
- AU
- Australia
- Prior art keywords
- immunodeficiency virus
- human immunodeficiency
- chimeric proteins
- recombinant poxvirus
- poxvirus
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 241000725303 Human immunodeficiency virus Species 0.000 title 1
- 108050006987 Poxvirus Proteins 0.000 title 1
- 108020001507 fusion proteins Proteins 0.000 title 1
- 102000037240 fusion proteins Human genes 0.000 title 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CU57/2001 | 2001-02-28 | ||
| CU20010057A CU23235A1 (en) | 2001-02-28 | 2001-02-28 | RECOMBINANT POXVIRUS FOR CHEMICAL PROTEINS OF THE HUMAN IMMUNODEFICIENCY VIRUS AND ITS APPLICATION IN THERAPEUTICS AND AIDS PREVENTION |
| PCT/CU2002/000001 WO2002068654A2 (en) | 2001-02-28 | 2002-02-22 | Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| AU2002237195A1 true AU2002237195A1 (en) | 2003-03-06 |
| AU2002237195B2 AU2002237195B2 (en) | 2007-01-04 |
Family
ID=40091626
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU2002237195A Ceased AU2002237195B2 (en) | 2001-02-28 | 2002-02-22 | Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US7318927B2 (en) |
| EP (1) | EP1371730B1 (en) |
| JP (1) | JP4125128B2 (en) |
| KR (1) | KR100920141B1 (en) |
| CN (1) | CN1526018B (en) |
| AR (1) | AR032871A1 (en) |
| AT (1) | ATE435916T1 (en) |
| AU (1) | AU2002237195B2 (en) |
| BR (2) | BR0206823A (en) |
| CA (1) | CA2430702C (en) |
| CU (1) | CU23235A1 (en) |
| DE (1) | DE60232862D1 (en) |
| ES (1) | ES2329768T3 (en) |
| RU (1) | RU2302461C2 (en) |
| WO (1) | WO2002068654A2 (en) |
| ZA (1) | ZA200304387B (en) |
Families Citing this family (17)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB9711957D0 (en) | 1997-06-09 | 1997-08-06 | Isis Innovation | Methods and reagents for vaccination |
| GB0118532D0 (en) | 2001-07-30 | 2001-09-19 | Isis Innovation | Materials and methods relating to improved vaccination strategies |
| CN101024842A (en) | 2001-11-07 | 2007-08-29 | 曼康公司 | Expression vectors encoding epitopes of target-associated antigens and its design method |
| JP2005517639A (en) | 2001-11-30 | 2005-06-16 | イシス イノベーション リミテッド | vaccine |
| GB0225786D0 (en) * | 2002-11-05 | 2002-12-11 | Glaxo Group Ltd | Vaccine |
| GB0225788D0 (en) | 2002-11-05 | 2002-12-11 | Glaxo Group Ltd | Vaccine |
| JP5052893B2 (en) * | 2003-02-20 | 2012-10-17 | アメリカ合衆国 | New insertion site in the pox vector |
| GB0417494D0 (en) | 2004-08-05 | 2004-09-08 | Glaxosmithkline Biolog Sa | Vaccine |
| US20080124355A1 (en) | 2006-09-22 | 2008-05-29 | David Gordon Bermudes | Live bacterial vaccines for viral infection prophylaxis or treatment |
| EP2620446A1 (en) | 2012-01-27 | 2013-07-31 | Laboratorios Del Dr. Esteve, S.A. | Immunogens for HIV vaccination |
| FR2987836A1 (en) * | 2012-03-09 | 2013-09-13 | Biomerieux Sa | INTERFERENCE PEPTIDES AND METHOD FOR DETECTING MICROORGANISMS |
| EP3741387A1 (en) * | 2012-09-28 | 2020-11-25 | Kline, Ellis | Glycosidase regimen for treatment of infectious disease |
| US11129906B1 (en) | 2016-12-07 | 2021-09-28 | David Gordon Bermudes | Chimeric protein toxins for expression by therapeutic bacteria |
| US11180535B1 (en) | 2016-12-07 | 2021-11-23 | David Gordon Bermudes | Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria |
| JP2022539417A (en) * | 2019-07-02 | 2022-09-08 | グリットストーン バイオ インコーポレイテッド | HIV antigen and MHC complex |
| CA3161633A1 (en) | 2019-11-14 | 2021-05-20 | Aelix Therapeutics, S.L. | Dosage regimens for vaccines |
| CN112852749A (en) * | 2021-03-27 | 2021-05-28 | 哈尔滨元亨生物药业有限公司 | Hybridoma cell strain C68 capable of efficiently secreting canine parvovirus monoclonal antibody and production method thereof by using bioreactor |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5174993A (en) * | 1981-12-24 | 1992-12-29 | Health Research Inc. | Recombinant avipox virus and immunological use thereof |
| US5505941A (en) | 1981-12-24 | 1996-04-09 | Health Research, Inc. | Recombinant avipox virus and method to induce an immune response |
| GB8918200D0 (en) | 1989-08-09 | 1989-09-20 | Medical Res Council | The peptide fragments of hiv |
| US7255862B1 (en) | 1996-11-14 | 2007-08-14 | Connaught Technology Corporation | ALVAC/FIV constructs |
-
2001
- 2001-02-28 CU CU20010057A patent/CU23235A1/en unknown
-
2002
- 2002-02-22 WO PCT/CU2002/000001 patent/WO2002068654A2/en active Application Filing
- 2002-02-22 JP JP2002568748A patent/JP4125128B2/en not_active Expired - Fee Related
- 2002-02-22 US US10/469,256 patent/US7318927B2/en not_active Expired - Fee Related
- 2002-02-22 DE DE60232862T patent/DE60232862D1/en not_active Expired - Lifetime
- 2002-02-22 KR KR1020037009273A patent/KR100920141B1/en active IP Right Grant
- 2002-02-22 AT AT02703488T patent/ATE435916T1/en not_active IP Right Cessation
- 2002-02-22 CA CA2430702A patent/CA2430702C/en not_active Expired - Fee Related
- 2002-02-22 BR BR0206823-0A patent/BR0206823A/en not_active IP Right Cessation
- 2002-02-22 BR BRPI0206823-0A patent/BRPI0206823B1/en unknown
- 2002-02-22 ES ES02703488T patent/ES2329768T3/en not_active Expired - Lifetime
- 2002-02-22 RU RU2003128991/13A patent/RU2302461C2/en not_active IP Right Cessation
- 2002-02-22 EP EP02703488A patent/EP1371730B1/en not_active Expired - Lifetime
- 2002-02-22 AU AU2002237195A patent/AU2002237195B2/en not_active Ceased
- 2002-02-22 CN CN028034139A patent/CN1526018B/en not_active Expired - Fee Related
- 2002-02-27 AR ARP020100686A patent/AR032871A1/en not_active Application Discontinuation
-
2003
- 2003-06-04 ZA ZA200304387A patent/ZA200304387B/en unknown
-
2006
- 2006-07-14 US US11/486,535 patent/US20080280354A1/en not_active Abandoned
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2002237195A1 (en) | Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus | |
| AU2002363296A1 (en) | Human secreted proteins | |
| AU2002329172A1 (en) | Human secreted proteins | |
| AU2003201727A1 (en) | Recombinant protein expression | |
| DE60232862D1 (en) | RECOMBINANT POX VIRUS FOR CHIMERIC PROTEINS OF THE HUMAN IMMUNE WEAK VIRUS | |
| AUPR546801A0 (en) | Recombinant antibodies | |
| AU2002331599A1 (en) | Epitopes of human immunodeficiency virus-1 | |
| AU2002300166A1 (en) | Process for the Preparation of Peptides | |
| AU2002233424A1 (en) | Peptides having affinity for the GP120 viral protein and use thereof | |
| AU2002322082A1 (en) | Pharmaceutical composition for the treatment of viral infection | |
| AU2002305903A1 (en) | Carbohydrate-associated proteins | |
| AU2002311620A1 (en) | Methods of making and using expression constructs for the expression of recombinant proteins | |
| AU2002342858A1 (en) | Human high-affinity antibody fragments for essential proteins of the hepatitis-c virus | |
| AU2002346056A1 (en) | Viral proteins capable of binding lar | |
| AU2002359310A1 (en) | Treating diseases mediated by metalloprotease-shed proteins | |
| AU2002316348A1 (en) | Chimeric capsid proteins and uses thereof | |
| AU2002254595A1 (en) | Method for enhancing the translation and expression of recombinant proteins | |
| AU2002257630A1 (en) | Human mrp5-like protein | |
| AU2002360333A1 (en) | Human angiomotin-like protein 1 | |
| AU2002357850A1 (en) | Neurotransmission-associated proteins | |
| AU2002365889A1 (en) | Regulated expression of recombinant dna | |
| AU2002326909A1 (en) | Neurotransmission-associated proteins | |
| AU2002357873A1 (en) | Carbohydrate-associated proteins | |
| AU2002308997A1 (en) | Protein preparation | |
| AU2002341202A1 (en) | Recombinant fusion proteins and the trimers thereof |